J
Jianda Hu
Researcher at Fujian Medical University
Publications - 212
Citations - 3640
Jianda Hu is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 23, co-authored 158 publications receiving 2463 citations.
Papers
More filters
Journal ArticleDOI
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Camille N. Abboud,Ellin Berman,Adam D. Cohen,Jorge E. Cortes,Daniel J. DeAngelo,Michael W. Deininger,Steven M. Devine,Brian J. Druker,Amir T. Fathi,Elias Jabbour,Madan Jagasia,Hagop M. Kantarjian,Jean Khoury,Pierre Laneuville,Richard A. Larson,Jeffrey H. Lipton,Joseph O. Moore,Tariq I. Mughal,Susan O'Brien,Javier Pinilla-Ibarz,Alfonso Quintás-Cardama,Jerald P. Radich,Vishnu Reddy,Charles A. Schiffer,Neil P. Shah,Paul J. Shami,Richard T. Silver,David S. Snyder,Richard Stone,Moshe Talpaz,Ayalew Tefferi,Richard A. Van Etten,Meir Wetzler,Elisabetta Abruzzese,Jane F. Apperley,Massimo Breccia,Jenny Byrne,Francisco Cervantes,Ekaterina Chelysheva,Richard E. Clark,Hugues de Lavallade,Iryna Dyagil,Carlo Gambacorti-Passerini,John M. Goldman,Ibrahim C. Haznedaroglu,Henrik Hjorth-Hansen,Tessa L. Holyoake,Brian J. P. Huntly,Philipp le Coutre,Elza Lomaia,Francois-Xavier Mahon,David Marin-Costa,Giovanni Martinelli,Jiri Mayer,Dragana Milojkovic,Eduardo Olavarria,Kimmo Porkka,Johan Richter,Philippe Rousselot,Giuseppe Saglio,Güray Saydam,Jesper Stentoft,Anna G. Turkina,Paolo Vigneri,Andrey Zaritskey,Alvaro Aguayo,Manuel Ayala,Israel Bendit,Raquel Bengió,Carlos Best,Eduardo Bullorsky,Eduardo Cervera,Carmino DeSouza,Ernesto Fanilla,David Gómez-Almaguer,Nelson Hamerschlak,José A. López,Alicia Magarinos,Luis Meillon,Jorge Milone,Beatriz Moiraghi,Ricardo Pasquini,Carolina Pavlovsky,Guillermo J. Ruiz-Argüelles,Nelson Spector,Christopher Arthur,Peter Browett,Andrew Grigg,Jianda Hu,Xiao-Jun Huang,Timothy P. Hughes,Qian Jiang,Saengsuree Jootar,Dong-Wook Kim,Hemant Malhotra,Pankaj Malhotra,Itaru Matsumura,Junia V. Melo,Kazunori Ohnishi,Ryuzo Ohno,Tapan Saikia,Anthony P. Schwarer,Naoto Takahashi,Constantine S. Tam,Tetsuzo Tauchi,Kensuke Usuki,Jianxiang Wang,Fawzi Abdel-Rahman,Mahmoud Aljurf,Ali Bazarbachi,Dina Ben Yehuda,Naeem Chaudhri,Muheez A. Durosinmi,Hossam Kamel,Vernon J. Louw,Bassam Francis Matti,Arnon Nagler,Pia Raanani,Ziad Salem +118 more
TL;DR: There is a need to (1) lower the prices of cancer drugs to allow more patients to afford them and (2) maintain sound long-term health care policies.
Journal ArticleDOI
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang,Zhaohui Gu,Zi-Xun Yan,Xia Zhao,Yin-Yin Xie,Zi-Guan Zhang,Chun-Ming Pan,Yuan Hu,Chang-Ping Cai,Ying Dong,Jinyan Huang,Li Wang,Yang Shen,Guoyu Meng,Jianfeng Zhou,Jianda Hu,Jin-Fen Wang,Yuan-Hua Liu,Lin-Hua Yang,Feng Zhang,Jianmin Wang,Zhao Wang,Zhigang Peng,Fang-Yuan Chen,Zi-Min Sun,Hao Ding,Jumei Shi,Jian Hou,Jin-Song Yan,Jing-Yi Shi,Lan Xu,Yang Li,Jing Lu,Zhong Zheng,Wen Xue,Wei-Li Zhao,Zhu Chen,Sai-Juan Chen +37 more
TL;DR: This work identified somatic gene mutations in 25 people with NKTCL by whole-exome sequencing and confirmed them in an extended validation group of 80 people by targeted sequencing, contributing to the understanding of the disease mechanism ofNKTCL.
Journal ArticleDOI
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.
Yuan-Fang Liu,Bai-Yan Wang,Bai-Yan Wang,Wei-Na Zhang,Jinyan Huang,Benshang Li,Ming Zhang,Lu Jiang,Jianfeng Li,Mingjie Wang,Yu-Jun Dai,Zi-Guan Zhang,Qiang Wang,Jie Kong,Bing Chen,Yong-Mei Zhu,Xiang-Qin Weng,Zhi-Xiang Shen,Junmin Li,Jin Wang,Xiaojing Yan,Yan Li,Yingmin Liang,Li Liu,Xie-Qun Chen,Wang-Gang Zhang,Jin-Song Yan,Jianda Hu,Shuhong Shen,Jing Chen,Long-Jun Gu,Deqing Pei,Yongjin Li,Gang Wu,Xin Zhou,Ruibao Ren,Cheng Cheng,Jun J. Yang,Kankan Wang,Shengyue Wang,Jinghui Zhang,Jian-Qing Mi,Ching-Hon Pui,Jingyan Tang,Zhu Chen,Sai-Juan Chen +45 more
TL;DR: Adult patients with B- cell acute lymphoblastic leukemia had more cooperative mutations and greater enrichment for alterations of epigenetic modifiers and genes linked to B-cell development, suggesting difference in the target cells of transformation between adult and pediatric patients and may explain in part the disparity in their responses to treatment.
Journal ArticleDOI
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial.
Yuankai Shi,Hang Su,Yongping Song,Wenqi Jiang,Xiuhua Sun,Wenbin Qian,Wei Zhang,Yuhuan Gao,Zhengming Jin,Jianfeng Zhou,Chuan Jin,Liqun Zou,Lugui Qiu,Wei Li,Jianmin Yang,Ming Hou,Shan Zeng,Qingyuan Zhang,Jianda Hu,Hui Zhou,Yan Xiong,Peng Liu +21 more
TL;DR: Sintilimab could be a new treatment option for patients with relapsed or refractory classical Hodgkin lymphoma in China and is registered with ClinicalTrials.gov, number NCT03114683.
Journal ArticleDOI
Treatment of Patients with Relapsed or Refractory Mantle-Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase.
Yuqin Song,Keshu Zhou,Dehui Zou,Jianfeng Zhou,Jianda Hu,Haiyan Yang,Huilai Zhang,Jie Ji,Wei Xu,Jie Jin,Fangfang Lv,Ru Feng,Sujun Gao,Haiyi Guo,Lei Zhou,Rebecca Elstrom,Jane Huang,William Novotny,Rachel Wei,Jun Zhu +19 more
TL;DR: These results demonstrate high and durable ORR and CR rates in patients with relapsed/refractory MCL and Zanubrutinib was generally well tolerated; grade ≥3 BTK inhibitor-associated toxicities were uncommon.